Not sure how I missed this first time around — via FDA.gov’s October 20, 2010 Enforcement Report (in the recall notices section):
. . . .PRODUCT
Cancidas® (Caspofungin acetate) for Injection, for Intravenous Use, 50 mg, NDC 0006-3822-10. Recall # D-014-2011
Lot 1553Y exp 6/30/2010
Recalling Firm: Merck Sharp & Dohme, West Point, PA, by letter June 7, 2010.
Manufacturer: Merck & Company, Inc., West Point, PA. Firm initiated recall is ongoing.
Lack of Assurance of Sterility (cracked vials).
VOLUME OF PRODUCT IN COMMERCE
CT, IL, MO, NY, TN, MA, OK, OH, FL, MI, PA, KY. . . .